Quarterly Statement Of Cash Flows

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7557411

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,815,463,000 JPY
6,157,566,000 JPY
Interest and dividends received
1,744,972,000 JPY
928,190,000 JPY
Interest paid
-118,420,000 JPY
-118,155,000 JPY
Income taxes paid
-1,437,995,000 JPY
-1,014,823,000 JPY
Net cash provided by (used in) operating activities
4,004,019,000 JPY
5,952,778,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,839,524,000 JPY
-1,543,090,000 JPY
Proceeds from sale of property, plant and equipment
11,757,000 JPY
904,000 JPY
Purchase of investment securities
-1,514,290,000 JPY
-521,827,000 JPY
Proceeds from sale of investment securities
83,995,000 JPY
JPY
Proceeds from collection of loans receivable
911,000 JPY
343,024,000 JPY
Other, net
-68,197,000 JPY
-4,899,000 JPY
Net cash provided by (used in) investing activities
-5,930,578,000 JPY
-4,268,545,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
10,300,000,000 JPY
JPY
Repayments of long-term borrowings
-5,468,121,000 JPY
-3,492,304,000 JPY
Dividends paid
-2,484,414,000 JPY
-826,530,000 JPY
Other, net
36,848,000 JPY
JPY
Net cash provided by (used in) financing activities
6,266,243,000 JPY
-4,911,983,000 JPY
Effect of exchange rate change on cash and cash equivalents
311,454,000 JPY
496,708,000 JPY
Net increase (decrease) in cash and cash equivalents
4,651,138,000 JPY
-2,731,043,000 JPY
Cash and cash equivalents
9,197,694,000 JPY
4,548,792,000 JPY
7,279,835,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.